Natera, Inc, a global leader in cell-free DNA and genetic testing, and MyOme, a leading clinical whole genome analysis and polygenic risk modeling company,...
Paige’s Robust Suite of AI-Powered Applications Delivers Greater Accuracy, Confidence and Efficiency for Breast Cancer Diagnosis and Reduces the Burden of Manual Diagnosis
Paige, a...
Veracyte, Inc. announced that new data show the use of the Prosigna Breast Cancer Assay altered treatment decisions for patients with early-stage breast cancer,...
Epic Sciences, Inc. announced that the company’s 56-gene ctDNA panel for genomic profiling of metastatic breast cancer is covered by the MolDX program (administered...
Theralink Technologies, Inc, a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, announced that it has acquired an exclusive...
